SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-057432
Filing Date
2017-09-15
Accepted
2017-09-15 16:54:39
Documents
8
Period of Report
2017-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-22039_38k.htm 8-K 31750
2 EX-1.1 a17-22039_3ex1d1.htm EX-1.1 286840
3 EX-5.1 a17-22039_3ex5d1.htm EX-5.1 18195
4 EX-99.1 a17-22039_3ex99d1.htm EX-99.1 11567
5 EX-99.2 a17-22039_3ex99d2.htm EX-99.2 11906
6 GRAPHIC g220393kii001.gif GRAPHIC 2645
7 GRAPHIC g220393moi001.gif GRAPHIC 3210
8 GRAPHIC g220393mmi001.gif GRAPHIC 3210
  Complete submission text file 0001104659-17-057432.txt   374352
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 171088459
SIC: 2834 Pharmaceutical Preparations